Stenocare A/S

STENO

DK0061078425

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 10:35:29 2024-04-26 am EDT			5-day change	1st Jan Change
4.99 ^DKK	0.00%		-4.41%	+96.46%

Apr. 18	Stenocare A/S Announces That the New STENOCARETHC/CBD Medical Cannabis Oil Product Available for Sale in Denmark	CI
Mar. 12	Stenocare A/S to Deliver New Medical Cannabis Oil Product for Australian Patients	CI

Stenocare A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023

February 22, 2024 at 02:00 am EST

Stenocare A/S reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was DKK 1.26 million compared to DKK 2.85 million a year ago. Net loss was DKK 4.25 million compared to DKK 3.34 million a year ago.

Latest news about Stenocare A/S

Stenocare A/S Announces That the New STENOCARETHC/CBD Medical Cannabis Oil Product Available for Sale in Denmark	Apr. 18	CI
Stenocare A/S to Deliver New Medical Cannabis Oil Product for Australian Patients	Mar. 12	CI
Stenocare Gets Nod for Sale of Medical Cannabis Oil Product in Denmark	Feb. 26	MT
STENOCARE Receives Approval to Sell a New Medical Cannabis Oil Product in Denmark	Feb. 26	CI
Stenocare A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI
Stenocare A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
Danish Medical Cannabis Group Stenocare Secures Refinancing Deal	Jan. 12	MT
Stenocare A/S Reaches Refinancing Agreement Covering All Existing Debt of DKK 8.2 Million	Jan. 12	CI
Stenocare Aims to Boost Sales in Australia via Quest Biotech Pharma Team up	Dec. 14	MT
Stenocare A/S Enters into A New Partnership Agreement with Quest Biotech Pharma	Dec. 14	CI
Stenocare A/S Expands Presence with New Medical Cannabis Oil Product	Nov. 23	CI
Stenocare A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Stenocare to Supply, Sell Medical Cannabis in Germany; Shares Surge	23-10-30	MT
Stenocare Ready to Ship Medical Cannabis to German Patients	23-10-30	CI
Stenocare A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-17	CI
Stenocare A/S Provides Sales Guidance for the Year 2023	23-08-17	CI
Stenocare A/S Provides Update on Their Strong Danish Product Pipeline	23-07-27	CI
Stenocare A/S Reports Earnings Results for the First Quarter Ended March 31, 2023	23-06-20	CI
Stenocare Raises DKK10.7 Million from Oversubscribed Rights Offering; Falls 10%	23-06-12	MT
Denmark’s Stenocare Teams Up with International Partner for New Cannabis Oil Product	23-06-02	MT
Stenocare A/S Reports on Significant Progress in Development of Its New Innovative Medical Cannabis Product	23-06-02	CI
Stenocare A/S Launches IT-Platform for Online Clinics	23-05-30	CI
Denmark's Stenocare Wins Regulatory Nod to Enter German Market	23-05-25	MT
Stenocare A/S Expands into Germany with Local Partner, ADREX Pharma	23-05-25	CI
Stenocare A/S Auditor Raises 'Going Concern' Doubt	23-03-15	CI

Chart Stenocare A/S

Duration

Period

More charts

Company Profile

STENOCARE A/S is a Denmark-based company, which is engaged in the production of medical cannabis products to patients. The Companyâs business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The Company distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

Sector

Pharmaceuticals

Calendar

2024-04-30 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
STENOCARE A/S	+96.46%	12.96M
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B

Alternative Medicine

Stenocare A/S

Equities

STENO

DK0061078425

Pharmaceuticals

Stenocare A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023

Latest news about Stenocare A/S

Chart Stenocare A/S

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Alternative Medicine